Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
As India's only legally approved GLP-1 provider, it ensures safe access to Semaglutide and Liraglutide under expert medical supervision
In preliminary results from a Phase 1 trial, ECC5004 displayed good tolerability and encouraged glucose and body weight reduction across the dose levels tested compared to the placebo
Tirzepatida acta sobre receptores de GLP-1 y de GIP
Either way, it's manageable
It helps regulate blood sugar levels and can lead to significant weight reduction
US$ 27.48
US$ 26.16
US$ 25.09
US$ 27.58
US$ 28.99
US$ 29.40
US$ 24.32
US$ 29.34
US$ 22.44
US$ 21.82
.webp)
US$ 23.23
US$ 20.60
US$ 28.19
